MedinCell initiates the first clinical trial of its Covid-19 prevention program September 29, 2020 September 29, 2020
Anti-PSMA/CD3 Bispecific Antibody Delivery and Antitumor Activity Using a Polymeric Depot Formulation September 20, 2020 September 20, 2020
MedinCell releases the results of its September 10, 2020 ordinary annual and extraordinary general meeting September 11, 2020 September 11, 2020
Participation terms in the MedinCell Combined General Meeting and availability of preparatory documents July 31, 2020 July 31, 2020
MedinCell announces the availability of its 2019/2020 Universal Registration Document including the Annual Financial Report July 29, 2020 July 29, 2020
MedinCell announces the great success of its capital increase and raises 15.6 M€ June 16, 2020 June 16, 2020
MedinCell successfully renegotiates the drawdown conditions of the last tranche of the EIB loan and secures an additional €5m of non-dilutive funding June 10, 2020 June 10, 2020
MedinCell announces fiscal year consolidated results April 2019 – March 2020 June 4, 2020 June 4, 2020
Videoconference and publication of the results for the 2019-2020 financial year, on June 4, 2020 May 25, 2020 May 25, 2020
Effects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle May 18, 2020 May 18, 2020
